Results 211 to 220 of about 5,723,129 (297)

Association between triglyceride-glucose index, placental inflammatory cytokines, and perinatal outcomes in preeclampsia. [PDF]

Front Endocrinol (Lausanne)
Mi Y, Zhu J, Gong P, He M, Hua Y.
europepmc   +1 more source

Changes in triglyceride-glucose index and progression of coronary artery calcification in asymptomatic adults: a longitudinal cohort study. [PDF]

Front Endocrinol (Lausanne)
Kim MJ, Kim YJ, Kang JH, Bae YS.
europepmc   +1 more source

Association of C-Reactive Protein-Triglyceride Glucose Index and TyG Index With Prehypertension and Hypertension. [PDF]

Immun Inflamm Dis
Yang S, Zhang Y, Zhou Z, Xu M, Feng L, Zu X.   +5 more
europepmc   +1 more source

The C-Reactive Protein-Triglyceride-Glucose Index and Functional Outcomes in Acute Ischemic Stroke Patients Following Endovascular Thrombectomy. [PDF]

Brain Behav
Bian J, Xu J, Li X, Ding X, Guo Y, Yang K, Huang X, Zhao S, Zhou Z, Li Z.   +9 more
europepmc   +1 more source

Vascular dysfunction in women with recurrent pregnancy loss: Possible association with antiphospholipid antibodies

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 206-214, April 2025.
Abstract Objective Antiphospholipid antibodies (aPL) are recognized to have a pivotal role in recurrent pregnancy loss (RPL) and cardiovascular disease. Therefore, we assessed the vascular function of women with RPL and examined the association with each type of aPL.
Titi Yang, Emi Okada, Maho Todoroki, Siyu Liu, Rukmali Athurupana, Kumie Kataoka, Chiaki Kashino, Takashi Mitsui, Toru Hasegawa, Yasuhiko Kamada, Hisashi Masuyama, Mikiya Nakatsuka   +11 more
wiley   +1 more source

Interaction Analysis of <i>VDR</i> rs7975232 Polymorphism and the Triglyceride-Glucose Index in Relation to Metabolic Outcomes in Older Adults. [PDF]

Int J Mol Sci
Michniewicz S, Chmielowiec K, Chmielowiec J, Czyżniewski B, Strowski MZ, Pruszyńska-Oszmałek E, Kołodziejski P, Kowalski MT, Grzywacz A, Gibas-Dorna M.   +9 more
europepmc   +1 more source

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto, Martha Gulati, Suvarna S. Khadilkar, Angela H. E. M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea R. Genazzani, Hema Divakar, Athena Poppas, on behalf of the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO)   +9 more
wiley   +1 more source